Fintel reports that on June 24, 2025, Barclays initiated coverage of West Pharmaceutical Services (NYSE:WST) with a ...

West Pharmaceutical Services Inc. closed 38.11% below its 52-week high of $352.33, which the company reached on October 24th.

Despite recent challenges, the long-term outlook for India's pharma sector remains strong, supported by government ...

U.S. District Chief Judge F. Dennis Saylor IV of the District of Massachusetts ordered Janssen Biotech, a wholly owned ...

West Pharmaceutical Services shares have dropped 35% in 2025, ... West Pharmaceuticals Services had $6.75 a share (non-GAAP) on $2.89 billion in revenues in FY2024.

Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He has long wanted to ...

Kennedy said that Pallone had previously been a champion of people who had been harmed by vaccines and only changed his tune ...

In today’s media landscape, you know what outrages me the most? Seeing those repetitive, dreamlike and misleading ...

China's growing biotech prowess has become a real threat to the industry in the US in recent years. Moves by the Trump administration could weaken the US market further, according to several experts ...

Piramal Pharma’s future is anchored in scaling its CDMO business to $1.2 billion, expanding complex hospital generics, and accelerating consumer healthcare growth, targeting overall revenues of $2 ...

Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2025 investor letter. A copy of ...